https://columbus.legistar.com/Gateway.aspx?M=LD&From=RSS&ID=7985386&GUID=B0F78B6F-1DFE-41D7-9C84-5BD7D26AF115Legistar15https://columbus.legistar.com/Gateway.aspx?M=LD&From=RSS&ID=7985386&GUID=B0F78B6F-1DFE-41D7-9C84-5BD7D26AF115B0F78B6F-1DFE-41D7-9C84-5BD7D26AF115-2026-04-16-18-59-46Title: To authorize the Board of Health to enter into contracts with (2) qualified vendors: Equitas Health, Inc. and Knupp & Watson & Wallman, Inc. for services for the period April 1, 2026 through September 29, 2026; to authorize the Board of Health to modify those contracts if portions of previously appropriated and encumbered funds are unused, and reallocate unused funds amongst the initial vendors without the need for additional legislation for Doxycycline Post-Exposure Prophylaxis Implementation Study grant program for the provision of services allowable under the grant; to authorize the expenditure of $183,000.00 from the Health Department Grants Fund to pay the costs thereof; and to declare an emergency. ($183,000.00)Thu, 16 Apr 2026 18:59:46 GMT